Back to Search Start Over

DOT1L inhibition enhances pluripotency beyond acquisition of epithelial identity and without immediate suppression of the somatic transcriptome.

Authors :
Wille CK
Sridharan R
Source :
Stem cell reports [Stem Cell Reports] 2022 Feb 08; Vol. 17 (2), pp. 384-396. Date of Electronic Publication: 2022 Jan 06.
Publication Year :
2022

Abstract

Inhibiting the histone 3 lysine 79 (H3K79) methyltransferase, disruptor of telomeric silencing 1-like (DOT1L), increases the efficiency of reprogramming somatic cells to induced pluripotent stem cells (iPSCs). Here, we find that, despite the enrichment of H3K79 methylation on thousands of actively transcribed genes in somatic cells, DOT1L inhibition (DOT1Li) does not immediately cause the shutdown of the somatic transcriptional profile to enable transition to pluripotency. Contrary to the prevalent view, DOT1Li promotes iPSC generation beyond the mesenchymal to epithelial transition and even from already epithelial cell types. DOT1Li is most potent at the midpoint of reprogramming in part by repressing Nfix that persists at late stages of reprogramming. Importantly, regulation of single genes cannot substitute for DOT1Li, demonstrating that H3K79 methylation has pleiotropic effects in maintaining cell identity.<br /> (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
2213-6711
Volume :
17
Issue :
2
Database :
MEDLINE
Journal :
Stem cell reports
Publication Type :
Academic Journal
Accession number :
34995500
Full Text :
https://doi.org/10.1016/j.stemcr.2021.12.004